GlassScriptPhysician profile
Justin Jordan
NPI 1699905638
$39,315.64
in general payments reported to CMS, 2019-2025
4 companies · $17K in 2025
The $17K reported for 2025 was more than what 92% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.02 · 2022: $3,390 · 2023: $3,900 · 2024: $15K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $1,311 · Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,207.99 |
| Travel and Lodging | $1,311.01 |
| Food and Beverage | $378.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22,514.47 | 2022-2025 | Koselugo |
| Springworks Therapeutics, INC. | $12,769.49 | 2024-2025 | Gomekli |
| Merck Sharp & Dohme LLC | $4,003.66 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $28.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.